You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CHLOROXINE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for chloroxine and what is the scope of freedom to operate?

Chloroxine is the generic ingredient in one branded drug marketed by Westwood Squibb and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for CHLOROXINE
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 137
Patent Applications: 1,529
DailyMed Link:CHLOROXINE at DailyMed

US Patents and Regulatory Information for CHLOROXINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Westwood Squibb CAPITROL chloroxine SHAMPOO;TOPICAL 017594-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

CHLOROXINE Market Analysis and Financial Projection Experimental

Chlorhexidine Gluconate Market Dynamics and Financial Trajectory

Market Overview

Chlorhexidine gluconate (CHG) is a widely used antiseptic and antimicrobial agent, primarily employed in healthcare settings for skin preparation before surgical procedures, hand hygiene, and wound care. The market for CHG solutions and cloths is driven by several key factors and faces various challenges.

Market Size and Forecast

  • The global chlorhexidine gluconate solution market was valued at USD 181.3 million in 2022 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 1.90% from 2023 to 2032, reaching USD 219.63 million by 2032[1].
  • In contrast, the chlorhexidine gluconate cloth market is projected to reach USD 15.46 billion by 2031, growing at a CAGR of 3.2% from 2024 to 2031[2].

Drivers of Market Growth

Increasing Surgical Procedures

The rising number of surgical procedures in hospitals is a significant driver for the CHG solution market. Chlorhexidine gluconate is essential for preoperative skin preparation and surgical hand scrub, reducing the risk of surgical site infections[1].

Growing Geriatric Population

The increasing geriatric population, particularly in regions like North America, Europe, and Asia-Pacific, contributes to higher healthcare spending and increased demand for CHG products. This demographic shift is expected to continue, with Asia-Pacific projected to have one in four people aged above 60 by 2050[1].

Economic Burden of Infections

The high cost associated with treating hospital-acquired infections (HAIs) prompts healthcare facilities to invest in preventive measures like CHG cloths, which offer a cost-effective solution by reducing infection rates[2].

Improved Supply Chain and Distribution

Enhanced global distribution networks and supply chains facilitate the accessibility of high-quality CHG cloths worldwide, supporting market growth[2].

Restraints and Challenges

Volatility in Raw Material Prices

Fluctuations in the prices of raw materials required for CHG solutions can restrain market growth by increasing production costs and affecting profitability[1].

Regulatory Challenges

The CHG cloth market is highly regulated, and obtaining necessary approvals from health authorities can be time-consuming and costly. Changes in regulations can also impact market dynamics[2].

Side Effects and Allergic Reactions

Chlorhexidine gluconate can cause skin irritation, allergic reactions, and in rare cases, severe anaphylactic responses, which can limit its usage, especially in patient populations prone to allergies[2].

Competition from Alternative Products

The presence of alternative antiseptic and antimicrobial products, such as iodine-based products and alcohol-based wipes, can compete with CHG products and restrain market growth[2].

High Costs and Limited Shelf Life

CHG cloths can be more expensive than traditional cleaning methods, and their limited shelf life poses challenges in inventory management and increases operational costs for healthcare providers and distributors[2].

Regional Analysis

North America

North America accounted for the largest revenue share in the CHG solution market in 2022, driven by excellent healthcare facilities and high healthcare spending in the United States. The region is expected to continue its robust market share due to stringent healthcare protocols and heightened awareness regarding infection control[1][2].

Europe

Europe is expected to grow at a steady rate, influenced by advanced healthcare infrastructure and a growing geriatric population. However, the region also faces strict regulatory frameworks governing the use and distribution of antiseptic products[1].

Asia-Pacific

The Asia-Pacific region is anticipated to register the fastest revenue growth rate due to growing healthcare investments, an increasing prevalence of HAIs, and expanding healthcare awareness. Countries like China and India are significantly contributing to this growth[1][2].

Middle East and Africa, Latin America

These regions represent growing markets with improving healthcare facilities and increased governmental focus on healthcare improvements. However, market penetration is challenged by socio-economic disparities and limited healthcare infrastructure in certain areas[2].

Competitive Landscape

The global CHG market is fragmented, with several key players dominating the market. Major companies such as Sage Products LLC (part of Stryker Corporation), 3M Company, GAMA Healthcare, and Medline Industries Inc. are employing strategies like mergers and acquisitions, strategic agreements, and the development of new products to maintain their market positions[1][2].

Distribution Channels

The market is segmented by distribution channels, including online and offline channels. The online segment is growing due to increased internet penetration and the convenience of online shopping, while offline channels remain significant due to the trust and immediate availability associated with traditional retail[4].

Key Takeaways

  • The CHG solution and cloth markets are driven by increasing surgical procedures, a growing geriatric population, and the economic burden of infections.
  • Regulatory challenges, side effects, competition from alternative products, and high costs are significant restraints.
  • North America and Europe are key markets, while Asia-Pacific is expected to show rapid growth.
  • The competitive landscape is fragmented with major players focusing on strategic expansions and product development.

FAQs

1. What is the current market size of the chlorhexidine gluconate solution market? The global chlorhexidine gluconate solution market size was USD 181.3 million in 2022[1].

2. What is the projected growth rate for the chlorhexidine gluconate cloth market? The chlorhexidine gluconate cloth market is projected to grow at a CAGR of 3.2% from 2024 to 2031[2].

3. Which region is expected to show the fastest revenue growth rate for CHG solutions? The Asia-Pacific region is anticipated to register the fastest revenue growth rate due to growing healthcare investments and an increasing prevalence of HAIs[1].

4. What are the main challenges facing the CHG market? The main challenges include volatility in raw material prices, regulatory challenges, side effects and allergic reactions, competition from alternative products, and high costs[1][2].

5. Who are the major players in the CHG market? Major players include Sage Products LLC (part of Stryker Corporation), 3M Company, GAMA Healthcare, and Medline Industries Inc.[1][2].

Cited Sources

  1. Emergen Research: Chlorhexidine Gluconate Solution Market Size - Emergen Research
  2. Verified Market Research: Chlorhexidine Gluconate CHg Cloth Market Size, Share & Forecast
  3. Market Research Intellect: Global Chlorhexidine Gluconate Cloth Market Size And Forecast
  4. Reports and Data: Chlorhexidine Gluconate Solution Market 2024 - Reports and Data

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.